634 related articles for article (PubMed ID: 19175565)
1. Establishment of a cell line expressing recombinant factor VII and its subsequent conversion to active form FVIIa through hepsin by genetic engineering method.
Halabian R; Roudkenar MH; Esmaeili NS; Masroori N; Roushandeh AM; Najafabadi AJ
Vox Sang; 2009 May; 96(4):309-15. PubMed ID: 19175565
[TBL] [Abstract][Full Text] [Related]
2. Expression and fast preparation of biologically active recombinant human coagulation factor VII in CHO-K1 cells.
Xiao W; Li CQ; Xiao XP; Lin FZ
Genet Mol Res; 2013 Dec; 12(4):6813-24. PubMed ID: 24391029
[TBL] [Abstract][Full Text] [Related]
3. Expression and purification of recombinant human coagulation factor VII fused to a histidine tag using Gateway technology.
Halabian R; Fathabad ME; Masroori N; Roushandeh AM; Saki S; Amirizadeh N; Najafabadi AJ; Gharehbaghian A; Roudkenar MH
Blood Transfus; 2009 Oct; 7(4):305-12. PubMed ID: 20011642
[TBL] [Abstract][Full Text] [Related]
4. The influence of different glycosylation patterns on factor VII biological activity.
Sutkeviciute I; Mistiniene E; Sereikaite J; Bumelis VA
Biochimie; 2009 Sep; 91(9):1123-30. PubMed ID: 19524011
[TBL] [Abstract][Full Text] [Related]
5. Characterization of mild coagulation factor VII deficiency: activity and clearance of the Arg315Trp and Arg315Lys variants in the Cys310-Cys329 loop (c170s).
Furlan Freguia C; Toso R; Pollak ES; Arruda VR; Pinotti M; Bernardi F
Haematologica; 2004 Dec; 89(12):1504-9. PubMed ID: 15590402
[TBL] [Abstract][Full Text] [Related]
6. Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.
Koizume S; Jin MS; Miyagi E; Hirahara F; Nakamura Y; Piao JH; Asai A; Yoshida A; Tsuchiya E; Ruf W; Miyagi Y
Cancer Res; 2006 Oct; 66(19):9453-60. PubMed ID: 17018600
[TBL] [Abstract][Full Text] [Related]
7. Role of hepsin in factor VII activation in zebrafish.
Khandekar G; Jagadeeswaran P
Blood Cells Mol Dis; 2014 Jan; 52(1):76-81. PubMed ID: 23954211
[TBL] [Abstract][Full Text] [Related]
8. Activation of a recombinant human factor VII structural analogue alters its affinity of binding to tissue factor.
Sridhara S; Chaing S; High KA; Blajchman MA; Clarke BJ
Am J Hematol; 1996 Oct; 53(2):66-71. PubMed ID: 8892729
[TBL] [Abstract][Full Text] [Related]
9. Differences in N-glycosylation of recombinant human coagulation factor VII derived from BHK, CHO, and HEK293 cells.
Böhm E; Seyfried BK; Dockal M; Graninger M; Hasslacher M; Neurath M; Konetschny C; Matthiessen P; Mitterer A; Scheiflinger F
BMC Biotechnol; 2015 Sep; 15():87. PubMed ID: 26382581
[TBL] [Abstract][Full Text] [Related]
10. Impaired secretion of carboxyl-terminal truncated factor VII due to an F7 nonsense mutation associated with FVII deficiency.
Tanaka R; Nakashima D; Suzuki A; Miyawaki Y; Fujimori Y; Yamada T; Takagi A; Murate T; Yamamoto K; Katsumi A; Matsushita T; Naoe T; Kojima T
Thromb Res; 2010 Mar; 125(3):262-6. PubMed ID: 19822353
[TBL] [Abstract][Full Text] [Related]
11. Genetic engineering, expression, and activity of a chimeric monoclonal antibody-avidin fusion protein for receptor-mediated delivery of biotinylated drugs in humans.
Boado RJ; Zhang Y; Zhang Y; Xia CF; Wang Y; Pardridge WM
Bioconjug Chem; 2008 Mar; 19(3):731-9. PubMed ID: 18278853
[TBL] [Abstract][Full Text] [Related]
12. [Cloning of human NKG2D gene and its expression in CHO cells].
Xu XQ; Chen XM; Zhang C; You L; Zhao CS; Wang JF; Zhang JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):447-9. PubMed ID: 16806005
[TBL] [Abstract][Full Text] [Related]
13. Characterization of porcine factor VII, X and comparison with human factor VII, X.
Chen Y; Qiao J; Tan W; Lu Y; Qin S; Zhang J; Li S; Bu H; Cheng J
Blood Cells Mol Dis; 2009; 43(1):111-8. PubMed ID: 19286401
[TBL] [Abstract][Full Text] [Related]
14. Interspecies exchange mutagenesis of the first epidermal growth factor-like domain of human factor VII.
Williamson V; Pyke A; Sridhara S; Kelley RF; Blajchman MA; Clarke BJ
J Thromb Haemost; 2005 Jun; 3(6):1250-6. PubMed ID: 15892860
[TBL] [Abstract][Full Text] [Related]
15. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa.
Reuning U; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1993 Feb; 69(2):197-204. PubMed ID: 8456434
[TBL] [Abstract][Full Text] [Related]
16. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
[TBL] [Abstract][Full Text] [Related]
17. Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation.
Kazama Y; Hamamoto T; Foster DC; Kisiel W
J Biol Chem; 1995 Jan; 270(1):66-72. PubMed ID: 7814421
[TBL] [Abstract][Full Text] [Related]
18. Influence of warfarin therapy on activated factor VII clotting activity.
Lippi G; Montagnana M; Salvagno GL; Poli G; Franchini M; Guidi GC
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):221-4. PubMed ID: 16575262
[TBL] [Abstract][Full Text] [Related]
19. Enhanced recombinant factor VII expression in Chinese hamster ovary cells by optimizing signal peptides and fed-batch medium.
Peng L; Yu X; Li C; Cai Y; Chen Y; He Y; Yang J; Jin J; Li H
Bioengineered; 2016 Apr; 7(3):189-97. PubMed ID: 27116572
[TBL] [Abstract][Full Text] [Related]
20. Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study.
Petersen LC; Nørby PL; Branner S; Sørensen BB; Elm T; Stennicke HR; Persson E; Bjørn SE
Thromb Res; 2005; 116(1):75-85. PubMed ID: 15850611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
